Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Martin DS, Stolfi RL, Sawyer RC. Martin DS, et al. Among authors: stolfi rl. Cancer Chemother Pharmacol. 1989;24(1):9-14. doi: 10.1007/BF00254098. Cancer Chemother Pharmacol. 1989. PMID: 2720896
Therapeutic effect reflected by plasma levels of a viral protein during combination chemotherapeutic treatment of mammary tumor-bearing mice.
Ritzi EM, Martin DS, Stolfi RL, Spiegelman S. Ritzi EM, et al. Among authors: stolfi rl. Cancer Res. 1985 Nov;45(11 Pt 1):5374-8. Cancer Res. 1985. PMID: 3840411
Plasma levels of a viral protein during adjuvant treatment: reflection of murine mammary tumor status and therapeutic effect.
Ritzi EM, Martin DS, Stolfi RL. Ritzi EM, et al. Among authors: stolfi rl. Cancer Res. 1986 Jun;46(6):2804-9. Cancer Res. 1986. PMID: 3754489
Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
Stolfi RL, Sawyer RC, Martin DS. Stolfi RL, et al. Cancer Res. 1987 Jan 1;47(1):16-20. Cancer Res. 1987. PMID: 3791203
Chemotherapeutic evaluation using clinical criteria in spontaneous, autochthonous murine breast tumors.
Stolfi RL, Stolfi LM, Sawyer RC, Martin DS. Stolfi RL, et al. Among authors: stolfi lm. J Natl Cancer Inst. 1988 Mar 2;80(1):52-5. doi: 10.1093/jnci/80.1.52. J Natl Cancer Inst. 1988. PMID: 3339639
Effect of Uridine on the Metabolism of 5-Fluorouracil in the CD8F 1 Murine Mammary Carcinoma System.
Sawyer RC, Stolfi RL, Spiegelman S, Martin DS. Sawyer RC, et al. Among authors: stolfi rl. Pharm Res. 1984 Mar;1(2):69-75. doi: 10.1023/A:1016351330832. Pharm Res. 1984. PMID: 24277215
Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumors.
Stolfi RL, Sawyer RC, Nayak R, Spiegelman S, Martin DS. Stolfi RL, et al. Cancer Res. 1980 Aug;40(8 Pt 1):2730-5. Cancer Res. 1980. PMID: 7388822
Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro.
Chou JL, Shen ZX, Stolfi RL, Martin DS, Waxman S. Chou JL, et al. Among authors: stolfi rl. Cancer Res. 1989 Oct 1;49(19):5371-6. Cancer Res. 1989. PMID: 2766303
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
Koutcher JA, Alfieri AA, Tsai JC, Matei C, Stolfi RL, Ballon D, Martin DS. Koutcher JA, et al. Among authors: stolfi rl. Cancer Invest. 1997;15(2):111-20. doi: 10.3109/07357909709115763. Cancer Invest. 1997. PMID: 9095206
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
Martin DS, Stolfi RL, Colofiore JR, Nord LD. Martin DS, et al. Among authors: stolfi rl. Anticancer Drugs. 1996 Aug;7(6):655-9. doi: 10.1097/00001813-199608000-00006. Anticancer Drugs. 1996. PMID: 8913434
54 results
Jump to page
Feedback